Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07MQJ
|
|||
| Former ID |
DNC013501
|
|||
| Drug Name |
(Z)-1-(4-phenyloxazol-2-yl)octadec-9-en-1-one
|
|||
| Synonyms |
CHEMBL177471; (Z)-1-(4-phenyloxazol-2-yl)octadec-9-en-1-one; SCHEMBL3185614; BDBM50163160
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C27H39NO2
|
|||
| Canonical SMILES |
CCCCCCCCC=CCCCCCCCC(=O)C1=NC(=CO1)C2=CC=CC=C2
|
|||
| InChI |
1S/C27H39NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19-22-26(29)27-28-25(23-30-27)24-20-17-16-18-21-24/h9-10,16-18,20-21,23H,2-8,11-15,19,22H2,1H3/b10-9-
|
|||
| InChIKey |
KOOKQMBHKMEODJ-KTKRTIGZSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Inhibitors of proteases and amide hydrolases that employ an alpha-ketoheterocycle as a key enabling functionality. Bioorg Med Chem. 2008 Feb 15;16(4):1562-95. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.